BRICKELL BIOTECH INC (BBI) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:BBI • US10802T2042

2.35 USD
+0.05 (+2.17%)
Last: Sep 7, 2022, 08:17 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to BBI. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 18.19. This target is 674.04% above the current price.
  • BBI was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BBI.
  • In the previous month the buy percentage consensus was at a similar level.
  • BBI was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
BBI Historical Analyst RatingsBBI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -58 -53 -48 -43 -38 -33 -28 -23 -18 -13 -8 -3 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 2.354.044.5918.1947.25 - 71.91% 95.32% 674.04% 1,910.64%

Related screens

Find peers 30% below price target
BBI Current Analyst RatingBBI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2022-08-16 HC Wainwright & Co. Maintains Buy
2022-05-13 Lake Street Downgrade Buy -> Hold
2022-03-08 William Blair Initiate Outperform
2022-01-18 HC Wainwright & Co. Initiate Buy

BRICKELL BIOTECH INC / BBI FAQ

What do analysts expect the price target to be for BRICKELL BIOTECH INC (BBI)?

8 analysts have analysed BBI and the average price target is 18.19 USD. This implies a price increase of 674.04% is expected in the next year compared to the current price of 2.35.


What is the consensus rating for BBI stock?

The consensus rating for BRICKELL BIOTECH INC (BBI) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.